| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.06M | 7.00M | 7.35M | 14.59M | 20.93M | 24.63M |
| Gross Profit | 1.31M | 1.47M | 1.61M | 2.51M | 2.64M | 3.42M |
| EBITDA | -4.33M | -2.55M | -3.23M | 5.39M | -5.01M | -8.58M |
| Net Income | -3.53M | -2.65M | -3.31M | 7.27M | -4.93M | -6.38M |
Balance Sheet | ||||||
| Total Assets | 16.90M | 15.24M | 21.40M | 24.25M | 30.22M | 33.52M |
| Cash, Cash Equivalents and Short-Term Investments | 10.09M | 8.86M | 16.37M | 11.92M | 5.66M | 4.51M |
| Total Debt | 1.98M | 1.49M | 3.20M | 4.40M | 6.12M | 11.83M |
| Total Liabilities | 7.13M | 7.29M | 9.15M | 9.15M | 23.14M | 19.59M |
| Stockholders Equity | 11.02M | 9.05M | 12.70M | 14.88M | 7.80M | 12.53M |
Cash Flow | ||||||
| Free Cash Flow | -3.51M | -2.97M | -754.00K | -1.25M | -35.00K | -4.67M |
| Operating Cash Flow | -2.94M | -2.40M | -456.00K | -1.17M | 238.00K | -3.98M |
| Investing Cash Flow | -2.89M | -3.23M | 3.82M | 11.77M | -267.00K | -578.00K |
| Financing Cash Flow | 6.95M | -1.88M | 1.12M | -4.82M | 1.91M | 5.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | S$29.16M | 4.77 | 14.32% | 1.25% | 33.55% | 2595.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | S$16.16M | 12.78 | 3.08% | ― | -8.21% | ― | |
46 Neutral | S$39.87M | -1.86 | -19.55% | 1.03% | -7.45% | -480.22% | |
45 Neutral | S$55.68M | -2.37 | -20.85% | ― | -2.43% | 52.80% | |
37 Underperform | S$11.35M | -2.47 | -31.32% | ― | -20.15% | -2.30% |
Matex International Limited, a company incorporated in Singapore, has announced a change in its Board of Directors. Mr. James Kho Chung Wah, currently an Independent Director, will be re-designated as the Independent Chairman of the Board effective 26 November 2025. Despite this change, the company acknowledges its current non-compliance with certain corporate governance rules and aims to address these issues by filling board and committee vacancies within three months.
Matex International Limited, a company incorporated in Singapore, has announced a significant legal expenditure of S$518,942.41 incurred over a 10-week period related to shareholder requisitions, lawsuits, and a settlement agreement. This expenditure represents approximately 93.5% of the company’s gross profit for the first half of 2025 and 5.3% of its net assets as of June 30, 2025. The Board is currently assessing the financial impact and seeking legal advice on the reasonableness of these expenses.
Matex International Limited, a company incorporated in Singapore, has received a letter of demand from Dr Tan Pang Kee and Mr Tan Guan Liang regarding cessation payments due under a settlement agreement. The letter demands payment by 18 November 2025, failing which legal action will be initiated. The company is seeking legal advice and will update shareholders as necessary.
Matex International Limited, a company incorporated in Singapore, has announced significant changes to its board and board committees, effective from November 5, 2025. The company appointed Mr. Chen Hongbo as the new CEO, while Dr. Danny Oh Beng Teck, Mr. Tan Chong Huat, and Mr. Yeo Hock Huat have resigned from their respective positions. These changes are seen as an opportunity for the company to reassess the size and composition of its board and committees, aligning with the Code of Corporate Governance 2018 and the Catalist Rules. The company plans to fill the vacancies within three months.
Matex International Limited has announced an update regarding its intended Extraordinary General Meeting (EGM) to seek shareholder approval for cessation payments to Dr Tan Pang Kee and Mr Tan Guan Liang. The Board plans to publish the notice for the EGM by December 19, 2025, aiming to hold the meeting in January 2026. The payments are classified as an ‘interested person transaction’ under Catalist Rules, and the company is working with legal advisors to ensure all relevant information is provided to shareholders.
Matex International Limited, a company incorporated in Singapore, has announced a change in its board of directors with the appointment of Dr. Liu Shen as Executive Director and Chief Technical Officer, effective from October 17, 2025. This appointment reflects the company’s strategic decision to strengthen its leadership team, although Dr. Liu Shen will not be part of any board committees, leaving the current committee compositions unchanged.
Matex International Limited held an Extraordinary General Meeting at the Suntec Singapore Convention & Exhibition Centre. The meeting was briefly adjourned to await announcements to the Singapore Exchange Securities Trading Limited, after which it resumed. The meeting introduced directors and proposed nominated directors, highlighting the company’s ongoing governance and strategic planning efforts.
Matex International Limited, a company incorporated in Singapore, has announced changes to its board and board committees effective from September 30, 2025. Mr. Tan Chong Huat has been re-designated as Non-Executive Independent Chairman and Chairman of the Remuneration Committee, while Mr. Chng Hee Kok and Mr. James Kho Chung Wah have also undergone re-designations within the board structure. These changes reflect the company’s efforts to align with the Catalist Rules of the Singapore Exchange Securities Trading Limited, potentially impacting its governance and strategic decision-making processes.
Matex International Limited, a company incorporated in Singapore, announced the discontinuance of two lawsuits, OA 733 and OA 790, following a court hearing and judgment. The court indicated that an injunction against the Subscription Agreements would have been granted if OA 733 had not been discontinued due to non-compliance with the company’s constitution. The trading suspension of the company’s securities remains in effect, and stakeholders are advised to stay informed through future announcements.
Matex International Limited has announced the termination of its subscription agreements with Ms. Lim Yan Peng and Ms. Gan Peiling, which were initially intended for the subscription of new shares in the company. This decision, made with the consent of all parties involved, will not result in any new share allotment or issuance, and no liabilities or obligations will arise from these agreements. The termination is not expected to materially impact the company’s net tangible assets or earnings per share for the financial year ending December 2025. The company’s trading suspension, effective since July 2025, remains in place, and stakeholders are advised to stay informed through further announcements.
Matex International Limited has entered into a settlement agreement involving the resignation of Dr. Tan Pang Kee and Mr. Tan Guan Liang from their positions within the company. The agreement includes financial settlements and non-compete clauses, and it also involves the termination of subscription agreements with Ms. Gan Peiling and Ms. Lim Yan Peng. This settlement is expected to impact the company’s operational dynamics and stakeholder relationships, potentially stabilizing its governance structure and market positioning.
Matex International Limited, a company incorporated in Singapore, has announced significant changes to its board and board committees, effective from September 16, 2025. The company has appointed Mr. Tan Chong Huat as the Non-Executive Non-Independent Chairman and Dr. Danny Oh Beng Teck as an Executive Director. Additionally, Mr. James Kho Chung Wah has been re-designated as Lead Independent Director, and Mr. Chng Hee Kok has been re-designated as the Chairman of the Remuneration Committee. These changes are expected to impact the company’s governance structure and strategic direction.
Matex International Limited has announced the cancellation of an extraordinary general meeting initially scheduled for September 11, 2025, due to developments in a legal matter identified as HC/OA 790/2025. The company’s securities remain suspended from trading since July 23, 2025, and stakeholders are advised to stay informed through further announcements.